Compazine and Dermatitis - a phase IV clinical study of FDA data

Summary:

Dermatitis is reported as a side effect among people who take Compazine (prochlorperazine maleate), especially for people who are female, 60+ old, also take Zofran, and have Pain.

The phase IV clinical study analyzes which people have Dermatitis when taking Compazine. It is created by eHealthMe based on reports of 13,599 people who have side effects when taking Compazine from the FDA, and is updated regularly.

What is Compazine?

Compazine has active ingredients of prochlorperazine maleate. It is often used in nausea and vomiting. eHealthMe is studying from 13,646 Compazine users. Check the latest studies of Compazine.

What is Dermatitis?

Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it) is found to be associated with 1,569 drugs and 1,229 conditions by eHealthMe. Check the latest studies of Dermatitis.

On Apr, 10, 2026

13,599 people reported to have side effects when taking Compazine.
Among them, 30 people (0.22%) have Dermatitis.

Among these 30 people:

What is the gender of people who have Dermatitis when taking Compazine? *

female: 65.38 %
male: 34.62 %

What is the age of people who have Dermatitis when taking Compazine? *

What are other drugs people take besides Compazine? *

What are other side effects people have besides Dermatitis? *

Rashes (redness): 18 people, 60.00%
Weakness: 13 people, 43.33%
Fatigue (feeling of tiredness): 12 people, 40.00%
Joint Pain: 10 people, 33.33%
Stress And Anxiety: 9 people, 30.00%
Muscle Aches (muscle pain): 9 people, 30.00%
Diarrhea: 8 people, 26.67%
Cellulitis (infection under the skin): 8 people, 26.67%
Weight Decreased: 7 people, 23.33%
Anaemia (lack of blood): 7 people, 23.33%

What are the existing conditions these people have? *

Pain: 5 people, 16.67%
Breast Cancer: 4 people, 13.33%
Itching: 3 people, 10.00%
Metastases To Bone (cancer spreads to bone): 3 people, 10.00%
Dizziness: 3 people, 10.00%
Multiple Myeloma (cancer of the plasma cells): 2 people, 6.67%
Neuralgia (pain in one or more nerves): 2 people, 6.67%
High Blood Pressure: 2 people, 6.67%
Neoplasm Malignant (cancer tumour): 2 people, 6.67%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Compazine and have Dermatitis?

- Check whether Dermatitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Compazine:

Compazine (13,646 reports)

Dermatitis treatments and more:

Dermatitis (30,577 reports)

Browse all side effects of Compazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermatitis:

Dermatitis (1,569 drugs)

Browse all the conditions that are associated with Dermatitis:

Dermatitis (1,229 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on prochlorperazine maleate (the active ingredients of Compazine) and Compazine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.